Assessing Symptom Burden in Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Patients

Juan Garza, Jane Margret Anderson, Robyn M. Scherber

Producción científica: Review articlerevisión exhaustiva

Resumen

Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes are rare types of chronic myeloid hematologic neoplasms. Patients with overlap syndrome have similar clinical features, mutations, and disease course, to other chronic myeloid malignancies. Limited data also suggests that overlap syndromes patients experience long standing and at times poorly controlled symptoms that may be underrecognized. In this article, we discuss the etiologies of symptoms in patients with overlap syndromes and currently available symptom burden assessment tools. Overall, symptom burden is an important consideration in patients with overlap syndrome, and efforts are ongoing to further investigate symptom burden and quality of life in this population.

Idioma originalEnglish (US)
Páginas (desde-hasta)475-489
Número de páginas15
PublicaciónHematology/Oncology Clinics of North America
Volumen34
N.º2
DOI
EstadoPublished - abr 2020

ASJC Scopus subject areas

  • Hematology
  • Oncology

Huella

Profundice en los temas de investigación de 'Assessing Symptom Burden in Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Patients'. En conjunto forman una huella única.

Citar esto